Northern Trust’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,085
| Closed | -$9.32K | – | 4488 |
|
|
2024
Q1 | $9.32K | Hold |
1,085
| – | – | ﹤0.01% | 4392 |
|
|
2023
Q4 | $3.8K | Hold |
1,085
| – | – | ﹤0.01% | 4463 |
|
|
2023
Q3 | $3.86K | Hold |
1,085
| – | – | ﹤0.01% | 4447 |
|
|
2023
Q2 | $6.31K | Hold |
1,085
| – | – | ﹤0.01% | 4500 |
|
|
2023
Q1 | $41K | Buy |
1,085
+218
| +25% | +$7.14K | ﹤0.01% | 4301 |
|
|
2022
Q4 | $25.8K | Hold |
867
| – | – | ﹤0.01% | 4434 |
|
|
2022
Q3 | $29K | Hold |
867
| – | – | ﹤0.01% | 4470 |
|
|
2022
Q2 | $35K | Hold |
867
| – | – | ﹤0.01% | 4516 |
|
|
2022
Q1 | $46K | Hold |
867
| – | – | ﹤0.01% | 4548 |
|
|
2021
Q4 | $48K | Hold |
867
| – | – | ﹤0.01% | 4601 |
|
|
2021
Q3 | $67K | Hold |
867
| – | – | ﹤0.01% | 4489 |
|
|
2021
Q2 | $113K | Buy |
+867
| New | +$120K | ﹤0.01% | 4334 |
|
|
2019
Q4 | – | Sell |
-204
| Closed | -$18K | – | 4308 |
|
|
2019
Q3 | $18K | Hold |
204
| – | – | ﹤0.01% | 4161 |
|
|
2019
Q2 | $28K | Hold |
204
| – | – | ﹤0.01% | 4140 |
|
|
2019
Q1 | $56K | Buy |
204
+49
| +32% | +$10.6K | ﹤0.01% | 4024 |
|
|
2018
Q4 | $20K | Hold |
155
| – | – | ﹤0.01% | 4156 |
|
|
2018
Q3 | $64K | Buy |
155
+18
| +13% | +$8.33K | ﹤0.01% | 4101 |
|
|
2018
Q2 | $74K | Buy |
137
+19
| +16% | +$10.1K | ﹤0.01% | 4065 |
|
|
2018
Q1 | $54K | Hold |
118
| – | – | ﹤0.01% | 4071 |
|
|
2017
Q4 | $79K | Sell |
118
-7
| -6% | -$4.23K | ﹤0.01% | 4015 |
|
|
2017
Q3 | $79K | Hold |
125
| – | – | ﹤0.01% | 4002 |
|
|
2017
Q2 | $60K | Hold |
125
| – | – | ﹤0.01% | 4057 |
|
|
2017
Q1 | $94K | Buy |
125
+69
| +123% | +$61.9K | ﹤0.01% | 3963 |
|
|
2016
Q4 | $55K | Buy |
+56
| New | +$64K | ﹤0.01% | 4001 |
|
Other funds holding TCON
Northern Trust's TCON Position: Q2 2024 in Review
Northern Trust sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 1,085 shares — an estimated $9.32K sold.
Northern Trust first reported a position in TCON in Q4 2016 and held it in 24 quarters. The position peaked at $113K in Q2 2021. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.
- Northern Trust reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Northern Trust sold 1,085 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $9.32K.
- Northern Trust first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 24 quarters.
- Northern Trust's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $113K in Q2 2021.
- 1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.